C

ChromaDex Corp
D

CDXC

2.74000
USD
-0.24
(-8.05%)
مغلق
حجم التداول
48,688
الربح لكل سهم
0
العائد الربحي
0
P/E
-205
حجم السوق
464,331,133
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACIU
    -0.24000
    (-5.91%)
    3.82000 USD
    K
    KALA
    -0.29000
    (-4.40%)
    6.30000 USD
    P
    PRQR
    -0.10000
    (-5.24%)
    1.81000 USD
    P
    PSTX
    -0.22500
    (-6.36%)
    3.31500 USD
    R
    RGNX
    -0.920
    (-6.44%)
    13.370 USD
الأخبار
المقالات

العنوان: ChromaDex Corp

القطاع: Consumer Defensive
الصناعة: Packaged Foods
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.